Volume 30, Supplement - Infectious Diseases and Carceral Health
SUPPLEMENT ISSUE
Outbreaks and Investigations
Health Belief Model to Assess Mpox Knowledge, Attitudes, and Practices among Residents and Staff, Cook County Jail, Illinois, USA, July–August 2022
Abstract
In summer 2022, a case of mpox was confirmed in a resident at the Cook County Jail (CCJ) in Chicago, Illinois, USA. We conducted in-depth interviews with CCJ residents and staff to assess mpox knowledge, attitudes, and practices; hygiene and cleaning practices; and risk behaviors. We characterized findings by using health belief model constructs. CCJ residents and staff perceived increased mpox susceptibility but were unsure about infection severity; they were motivated to protect themselves but reported limited mpox knowledge as a barrier and desired clear communication to inform preventive actions. Residents expressed low self-efficacy to protect themselves because of contextual factors, including perceived limited access to cleaning, disinfecting, and hygiene items. Our findings suggest correctional facilities can support disease prevention by providing actionable and tailored messages; educating residents and staff about risk and vaccination options; and ensuring access to and training for hygiene, cleaning, and disinfecting supplies.
In May 2022, mpox cases were identified in several nonendemic countries, including the United States, predominately among gay, bisexual, and other men who have sex with men (1–4). During the outbreak, transmission frequently occurred from contact with mpox lesions on the skin or mucosal surfaces during sexual activity (5). In summer 2022, vaccination campaigns began for persons exposed to or at higher risk for mpox (6,7).
Persons living in congregate settings, such as correctional and detention facilities, are at increased risk for many infectious diseases. Monkeypox virus (MPXV) transmission has been linked to communal housing and types of activities common in correctional facilities, including sharing clothing, linens, and personal items (8). In addition, access to hygiene and sanitation supplies in such facilities is sometimes limited (9). Mpox outbreaks were identified in correctional facilities in Nigeria, but the mode of transmission was not identified (10,11). At the time of this investigation, little was known about the acceptability and feasibility of mpox vaccination in correctional facility settings.
On July 22, 2022, mpox was confirmed in a person detained in Cook County Jail (CCJ) in Chicago, Illinois, USA (12), the first mpox case identified in a US correctional or detention facility. The Chicago Department of Public Health (CDPH) and the Centers for Disease Control and Prevention (CDC) investigated and found no higher-risk exposures or additional cases. CDPH and CDC determined that transmission in similar settings might be limited in the absence of higher-risk exposures, such as sexual contact (12). We conducted interviews at CCJ to assess mpox knowledge, attitudes, and practices among residents and staff; evaluate the acceptability and feasibility of vaccination for postexposure prophylaxis for mpox among residents; and identify information to include in mpox education materials for persons living and working in similar facilities.
Study Participants
During August 2–4, 2022, we conducted in-depth interviews with CCJ residents and staff. Among 57 potentially exposed residents who had shared a dormitory-style housing unit with the mpox case-patient, 19 were still residing in CCJ at the time of the investigation. We invited all 19 residents to participate, in addition to a purposeful convenience sample of 13 staff member who worked in various roles at CCJ during our investigation. Staff provided verbal consent; residents provided written consent by making a nonidentifying mark on a document that included details of the interview process, voluntary nature of participation, and confidentiality protections. This investigation was part of a public health response to an ongoing outbreak. It was reviewed and approved by CDC and conducted consistent with applicable federal law and CDC policy (13–17).
Data Collection
We developed a semistructured interview guide with questions on knowledge, attitudes, and practices regarding mpox and postexposure prophylaxis, hygiene and cleaning practices, and behaviors in jail that could lead to mpox transmission. Resident interviews were conducted in semiprivate spaces, far enough away from other residents and staff to provide audio privacy. A custody officer remained nearby, maintaining visual contact. Staff interviews were conducted in private spaces. All resident interviews were conducted by 2 interviewers, 1 leading the interview and 1 taking detailed notes. Some staff interviews were conducted by a single interviewer because of time constraints. All interviewers were trained on in-depth interview techniques, and interviews lasted ≈30–45 minutes.
Data Analysis
We analyzed data in 2 phases. First, we developed an a priori matrix to organize and analyze findings (18–20) to make evidence-based recommendations to improve immediate mpox response activities (12). Columns included predetermined topics aligned with interview questions. We entered participant responses into each row and summarized responses across row and topic, enabling rapid identification of findings. Key themes were compiled by reviewing the matrix entries, interview notes and summaries, and organizing findings and common themes. The study team discussed themes to summarize and reach consensus.
We later reassessed those data using the health belief model, a framework used to understand health behaviors and develop strategies to motivate behavior change (21,22). The model includes predictors for human behavior, such as perceived susceptibility to a disease or condition, perceived severity of illness, perceived benefits to taking action, perceived barriers to action, cues to action, and self-efficacy (21,22). Organizing the data around that framework further informed health promotion efforts in CCJ and similar settings.
Of 19 eligible residents, 16 (84%) consented to participate; all 13 staff consented. Residents ranged in age from 21 to 62 (median 43) years; all identified as male and as heterosexual/straight (Table 1). Nine (56%) identified as non-Hispanic Black, 4 (25%) non-Hispanic White, 2 (13%) Hispanic/Latino, and 1 (5%) non-Hispanic Asian. Participants spent 1–7 (median 5) nights in the same housing unit as the resident with mpox. Among the 13 staff, 7 (54%) worked in healthcare, 4 (31%) in custody, and 2 in other roles (Table 2). Interview themes were organized within the health belief model constructs (Table 3).
Perceived Susceptibility to Mpox
Residents reported varied levels of concern about mpox, from not concerned at all to very concerned, and felt that residing in CCJ heightened their risk. Some residents reported keeping to themselves and therefore felt their risk was low. However, most residents were concerned about factors outside their control, such as communal housing, that could increase their risk. For some residents, their heightened sense of susceptibility led to more conservative behaviors, such as frequent handwashing and avoiding social interactions or recreational activities.
Similarly, although staff thought their risk for MPXV infection was low, they perceived working in a jail inherently increased their risk for contracting infectious diseases. Some staff expressed confidence in their knowledge of infection prevention and control practices, such as using personal protective equipment, but others understood those tools might not guarantee protection.
Perceived Severity of Potential Mpox Illness
Residents and staff were unsure how severe illness would be if they contracted mpox. However, some drew connections to COVID-19 and wondered if persons with weakened immune systems or underlying conditions would have more severe illness.
Perceived Benefits of Behavior Change to Prevent Mpox
Residents and staff described several benefits to mpox prevention behaviors, including preventing transmission to their families. Residents were concerned that quarantining or isolating because of mpox exposure or MPXV infection could delay their release from jail. Those concerns motivated residents to want to protect themselves, but they felt they did not have sufficient knowledge about prevention options. Several residents felt they did not receive adequate information about the vaccine when it was offered, including information on safety and side effects (12). However, some residents reported they chose to get vaccinated, relying on previous knowledge that vaccination reduces risk for other illnesses.
Perceived Barriers to Mpox Preventive Actions
Limited Knowledge and Rumors about Mpox
Most residents and some nonhealthcare staff described limited knowledge about mpox symptoms, prevention, or vaccines as a barrier to preventive action. Many residents reported they first heard about mpox while detained in CCJ, after news about the mpox case in CCJ was reported to the public. Many residents did not remember being notified by staff about possible exposure or reported that the information was difficult to understand because it was provided to the entire housing unit at once. Residents wanted more information about the vaccine and other prevention options.
At the time of interviews, healthcare staff had recently completed an online mpox training, covering transmission, prevention, and vaccines, which they felt provided knowledge to protect themselves. Nonhealthcare staff had varying levels of mpox knowledge. Like residents, most staff reported their mpox-related information came from the news or others in CCJ, including information about the mpox case at CCJ; they had not received mpox training, and they felt unsure how to protect themselves.
Several residents and staff reported hearing rumors that mpox was a “gay disease.” They reported being hesitant to believe the rumors and did not describe rumors as a barrier to taking preventive action. However, residents and staff mentioned those rumors spreading within CCJ and were concerned the rumors might act as a barrier for others.
Challenges Accessing Healthcare and Supplies
Many residents were willing to report potential mpox symptoms to healthcare staff but felt that follow-up on requests for healthcare services in general was inconsistent. Residents felt they had inadequate access to cleaning, disinfecting, and hygiene supplies. Residents were issued bar soap at no cost, but many reported quickly running out of soap because they used it for handwashing, showering, and washing dishes and clothes. Most residents felt there was not enough soap available, especially if they were unable to purchase additional soap from the commissary. Residents believed supplies provided to clean and disinfect their living spaces were ineffective because the disinfectant was unlabeled and smelled like vinegar. Residents also described challenges accessing brooms, mops, and buckets. Staff believed the disinfectant was in line with guidance for disinfectants for viral pathogens but felt residents were unsure how to use it.
Cues to Action to Engage in Mpox Prevention
The mpox case within CCJ was the cue to action for residents and staff to protect themselves; however, many residents and nonhealthcare staff did not feel they had the information or resources to do so. Participants desired timely, clear communication about possible mpox exposure and prevention options, which they felt they had not received. Participants felt clear communication would help quell rumors, enable persons to better protect themselves and others, and improve relationships among staff in different roles and between staff and residents.
Self-Efficacy to Engage in Mpox Preventive Actions
Self-efficacy to engage in mpox preventive actions varied. Many residents expressed low self-efficacy because of limited mpox knowledge, perceived limited access to healthcare and cleaning and hygiene supplies, perceived insufficient communication about their risk, and facility factors such as communal living. Healthcare staff reported greater self-efficacy because of medical training, knowledge and availability of personal protective equipment, and experience caring for patients with other infectious diseases. However, staff in other roles described limited self-efficacy because of more extended physical proximity to residents, including contact that was unpredictable and outside their control, limited knowledge of mpox and prevention methods, and perceived insufficient communication about their risk.
Our findings highlight the perspectives of jail staff and residents on communication, infection prevention, and vaccination after an mpox case was confirmed in CCJ. The rapid data analysis enabled us to provide real-time, stakeholder-informed recommendations to enhance mpox prevention and control efforts in CCJ and to create a toolkit to make those recommendations available to other correctional and detention facilities nationally (12,23–25).
Staff and residents at the jail described several barriers to engaging in mpox preventive actions: limited knowledge about mpox, risk, and postexposure prophylaxis; perceived insufficient communication about the mpox case and potential exposures; perceived inadequacy of cleaning and hygiene supplies among residents; and reported limitations in healthcare access among residents. Staff and residents had varied levels of self-efficacy but shared the need for clearer and more timely communication to prevent the spread of misinformation and empower them to make informed decisions.
Because of unique contextual factors related to disease transmission in correctional and detention facilities, providing tailored education and messages for residents and staff during public health emergencies and specific guidance about preventive actions available in these settings are critical (24,25). Previous studies have described the challenges of health promotion within correctional settings, including the influence of social networks and norms on health behaviors and the need to build rapport and trust to promote behavior change (26–28). In addition, ensuring residents and staff have access to sufficient hygiene supplies and that they know what cleaning and disinfecting supplies are available, how to request them, and how to properly use them is essential. Lessons learned from our findings and from past health education efforts in correctional settings, including during the COVID-19 pandemic (29–31), can inform strategies for future public health efforts.
The first limitation of our analysis is that interviews were limited to staff and residents in CCJ at the time of our investigation, and we were unable to speak to residents who had already left CCJ or staff not working during our investigation. Another limitation is that residents were within eyesight of custody officers during interviews, and some residents might have been uncomfortable disclosing sensitive information. Finally, our analysis was limited to a small sample and 1 facility; findings might not be generalizable to other settings.
In conclusion, correctional and detention facilities can support prevention of mpox and other infectious diseases by providing exposure notification and prevention messages that are destigmatizing, actionable, and tailored to the population and setting; by educating residents and staff about their infection risk and vaccination options; and by ensuring residents have access to sufficient hygiene, cleaning, and disinfecting supplies and training on how to use them. Including rapid qualitative analyses as part of the mpox case investigation helped accomplish timely development of setting-specific disease prevention tools that were informed by the residents and staff living and working in the affected facility. Rapid qualitative approaches, together with the inclusion of behavioral scientists and communication specialists to response teams, could be valuable additions to outbreak investigations of emerging infectious diseases in correctional settings. These tools can highlight population-specific challenges and barriers and provide actionable information for correctional settings to inform tailored prevention materials during future disease responses.
Ms. Hassan is an epidemiologist at the Centers for Disease Control and Prevention. Her research interests focus on infectious disease outbreak response and technical assistance to local, state, and tribal public health agencies.
Acknowledgment
We thank all Cook County Jail staff and residents who participated in interviews. We also thank Priscilla Auguston, Jesus Estrada, Jane Gubser, Bridgette Jones, and Sharon Welbel for their support of this work.
References
- Hennessee I, Shelus V, McArdle CE, Wolf M, Schatzman S, Carpenter A, et al.; California Department of Public Health Monkeypox Pediatric Working Group; CDC Monkeypox Pediatric Working Group. CDC Monkeypox Pediatric Working Group. Epidemiologic and clinical features of children and adolescents aged <18 years with monkeypox—United States, May 17–September 24, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1407–11. DOIPubMedGoogle Scholar
- Pfeiffer JA, Collingwood A, Rider LE, Minhaj FS, Matheny AM, Kling C, et al. High-contact object and surface contamination in a household of persons with monkeypox virus infection—Utah, June 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1092–4. DOIPubMedGoogle Scholar
- Spicknall IH, Pollock ED, Clay PA, Oster AM, Charniga K, Masters N, et al. Modeling the impact of sexual networks in the transmission of monkeypox virus among gay, bisexual, and other men who have sex with men—United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1131–5. DOIPubMedGoogle Scholar
- Kyaw NTT, Kipperman N, Alroy KA, Baumgartner J, Crawley A, Peterson E, et al. Notes from the field: clinical and epidemiologic characteristics of mpox cases from the initial phase of the outbreak—New York City, May 19–July 15, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1631–3. DOIPubMedGoogle Scholar
- Centers for Disease Control and Prevention. Science brief: detection and transmission of mpox (formerly monkeypox) virus during the 2022 clade IIb outbreak [cited 2023 Apr 25]. https://www.cdc.gov/poxvirus/mpox/about/science-behind-transmission.html
- Kriss JL, Boersma PM, Martin E, Reed K, Adjemian J, Smith N, et al. Receipt of first and second doses of JYNNEOS vaccine for prevention of monkeypox—United States, May 22–October 10, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1374–8. DOIPubMedGoogle Scholar
- Rao AK, Petersen BW, Whitehill F, Razeq JH, Isaacs SN, Merchlinsky MJ, et al. Use of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for preexposure vaccination of persons at risk for occupational exposure to orthopoxviruses: recommendations of the Advisory Committee on Immunization Practices—United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:734–42. DOIPubMedGoogle Scholar
- Nolen LD, Osadebe L, Katomba J, Likofata J, Mukadi D, Monroe B, et al. Introduction of monkeypox into a community and household: risk factors and zoonotic reservoirs in the Democratic Republic of the Congo. Am J Trop Med Hyg. 2015;93:410–5. DOIPubMedGoogle Scholar
- Turabelidze G, Lin M, Wolkoff B, Dodson D, Gladbach S, Zhu BP. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerg Infect Dis. 2006;12:422–7. DOIPubMedGoogle Scholar
- Pembi E, Omoleke S, Paul H, Augustine T, Cuevas LE. Monkeypox outbreak in a correctional center in North Eastern Nigeria. J Infect. 2022;85:702–69. DOIPubMedGoogle Scholar
- Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al.; CDC Monkeypox Outbreak Team. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis. 2019;19:872–9. DOIPubMedGoogle Scholar
- Hagan LM, Beeson A, Hughes S, Hassan R, Tietje L, Meehan AA, et al. Monkeypox Case Investigation - Cook County Jail, Chicago, Illinois, July-August 2022. MMWR Morb Mortal Wkly Rep. 2022;71:1271–7. DOIPubMedGoogle Scholar
- US Department of Health and Human Services. Protection of human subjects. 45 CFR §46. Revised 2018 Jul 19 [cited 2023 Apr 25]. https://www.hhs.gov/ohrp/regulations-and-policy/regulations/revised-common-rule-regulatory-text/index.html
- Food and Drug Administration. 21 CFR part 56: Institutional review boards [cited 2023 Apr 25]. https://www.ecfr.gov/on/2018-07-19/title-21/chapter-I/subchapter-A/part-56
- United States Code. 42 USC §241: Research and investigations generally [cited 2023 Apr 25]. https://www.govinfo.gov/content/pkg/USCODE-2010-title42/html/USCODE-2010-title42-chap6A.htm
- United States Code. 5 USC section §552a. Records maintained on individuals. [cited 2023 Apr 25]. https://www.govinfo.gov/content/pkg/USCODE-2022-title5/pdf/USCODE-2022-title5-partI-chap5-subchapII-sec552a.pdf
- United States Code. 44 USC section 3501: Public printing and documents [cited 2023 Apr 25]. https://www.govinfo.gov/content/pkg/USCODE-2021-title44/pdf/USCODE-2021-title44.pdf
- Gale RC, Wu J, Erhardt T, Bounthavong M, Reardon CM, Damschroder LJ, et al. Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration. Implement Sci. 2019;14:11. DOIPubMedGoogle Scholar
- Keniston A, McBeth L, Astik G, Auerbach A, Busch J, Kangelaris KN, et al. Practical applications of rapid qualitative analysis for operations, quality improvement, and research in dynamically changing hospital environments. Jt Comm J Qual Patient Saf. 2023;49:98–104. DOIPubMedGoogle Scholar
- Watkins DC. Rapid and rigorous qualitative data analysis: the “RADaR” technique for applied research. Int J Qual Methods. 2017;16:
1609406917712131 . DOIGoogle Scholar - Abraham C, Sheeran P. The health belief model. In: Conner M, Norman P, editors. Predicting health behaviour: research and practice with social cognition models, 3rd ed. Berkshire (UK): Open University Press; 2015. p. 30–55.
- Champion VL, Skinner CS. The health belief model. In: Glanz K, Rimer BK, Viswanath K, editors. Health behavior and health education: theory, research, and practice, 4th edition. Hoboken (NJ): Jossey-Bass; 2008. p. 45–65.
- Vixama G, Hughes SE, Afanuh S; National Institute for Occupational Safety and Health (NIOSH). Safe and proper use of disinfectants to reduce viral surface contamination in correctional facilities (poster). Publication no. 2023–127. Cincinnati: The Institute; 2023.
- Centers for Disease Control and Prevention. Considerations for reducing mpox transmission in congregate living settings [cited 2023 Nov 17]. https://www.cdc.gov/poxvirus/mpox/community/congregate.html
- Centers for Disease Control and Prevention. Mpox informational poster for correctional and detention facilities [cited 2023 Nov 17]. https://archive.cdc.gov/#/details?url=https://www.cdc.gov/poxvirus/mpox/pdf/Mpox-Corrections-toolkit.pdf
- Devilly GJ, Sorbello L, Eccleston L, Ward T. Prison-based peer-education schemes. Aggress Violent Behav. 2005;10:219–40. DOIGoogle Scholar
- Erfani P, Sandoval RS, Rich KM, Ojo A, Walker L, White-Hammond G, et al. Ask Me Anything": Lessons learned in implementing a COVID-19 vaccine information initiative in Massachusetts jails. Vaccine. 2022;40:2981–3. DOIPubMedGoogle Scholar
- Haynie DL, Whichard C, Kreager DA, Schaefer DR, Wakefield S. Social networks and health in a prison unit. J Health Soc Behav. 2018;59:318–34. DOIPubMedGoogle Scholar
- Andrews ME, Mattan BD, Richards K, Moore-Berg SL, Falk EB. Using first-person narratives about healthcare workers and people who are incarcerated to motivate helping behaviors during the COVID-19 pandemic. Soc Sci Med. 2022;299:
114870 . DOIPubMedGoogle Scholar - Kramer C, Song M, Sufrin CB, Eber GB, Rubenstein LS, Saloner B. COVID-19 vaccination hesitancy and uptake: Perspectives from people released from the Federal Bureau of Prisons. Vaccine. 2023;41:1408–17. DOIPubMedGoogle Scholar
- Ortiz-Paredes D, Varsaneux O, Worthington J, Park H, MacDonald SE, Basta NE, et al. Reasons for COVID-19 vaccine refusal among people incarcerated in Canadian federal prisons. PLoS One. 2022;17:
e0264145 . DOIPubMedGoogle Scholar
Tables
Cite This ArticleOriginal Publication Date: March 31, 2024
Table of Contents – Volume 30, Supplement—March 2024
EID Search Options |
---|
Advanced Article Search – Search articles by author and/or keyword. |
Articles by Country Search – Search articles by the topic country. |
Article Type Search – Search articles by article type and issue. |
Please use the form below to submit correspondence to the authors or contact them at the following address:
Rashida Hassan, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H21-6, Atlanta, GA 30329-4018, USA
Top